对美国血液供应进行西尼罗河病毒筛查：血液、金钱与合理性问题
Screening the United States blood supply for West Nile Virus: a question of blood, dollars, and sense.
作者信息
Lee Bruce Y, Biggerstaff Brad J
机构信息
Section of Decision Sciences and Clinical Systems Modeling, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
出版信息
PLoS Med. 2006 Feb;3(2):e99. doi: 10.1371/journal.pmed.0030099. Epub 2006 Jan 24.
Abstract
Lee and Biggerstaff discuss two new studies on the cost effectiveness of different strategies for screening blood for West Nile virus.
摘要
李和比格斯塔夫讨论了两项关于筛查西尼罗河病毒血液不同策略成本效益的新研究。
相似文献
1
Screening the United States blood supply for West Nile Virus: a question of blood, dollars, and sense.
PLoS Med. 2006 Feb;3(2):e99. doi: 10.1371/journal.pmed.0030099. Epub 2006 Jan 24.
2
Studies propose targeted screening of blood for West Nile virus.
JAMA. 2006 Mar 15;295(11):1235-6. doi: 10.1001/jama.295.11.1235.
3
As West Nile virus season heats up, blood safety testing lags behind.
JAMA. 2003 May 14;289(18):2341-2. doi: 10.1001/jama.289.18.2341.
4
West Nile virus.
N Engl J Med. 2003 Nov 6;349(19):1873-4; author reply 1873-4. doi: 10.1056/NEJM200311063491921.
5
The development of West Nile virus safety policies by Canadian blood services: guiding principles and a comparison between Canada and the United States.
Transfus Med Rev. 2006 Apr;20(2):97-109. doi: 10.1016/j.tmrv.2005.11.001.
6
Update: West Nile virus screening of blood donations and transfusion-associated transmission--United States, 2003.
MMWR Morb Mortal Wkly Rep. 2004 Apr 9;53(13):281-4.
7
Detection of West Nile virus in blood donations--United States, 2003.
MMWR Morb Mortal Wkly Rep. 2003 Aug 15;52(32):769-72.
8
Cost-effectiveness of alternative blood-screening strategies for West Nile Virus in the United States.
PLoS Med. 2006 Feb;3(2):e21. doi: 10.1371/journal.pmed.0030021. Epub 2006 Jan 24.
9
Update: Detection of West Nile virus in blood donations--United States, 2003.
MMWR Morb Mortal Wkly Rep. 2003 Sep 26;52(38):916-9.
10
West Nile virus. Blood banks in a 'race against the mosquitoes'.
Science. 2003 Mar 21;299(5614):1824. doi: 10.1126/science.299.5614.1824.
引用本文的文献
1
A 20-year historical review of West Nile virus since its initial emergence in North America: Has West Nile virus become a neglected tropical disease?
PLoS Negl Trop Dis. 2021 May 6;15(5):e0009190. doi: 10.1371/journal.pntd.0009190. eCollection 2021 May.
2
Re-designing the Mozambique vaccine supply chain to improve access to vaccines.
Vaccine. 2016 Sep 22;34(41):4998-5004. doi: 10.1016/j.vaccine.2016.08.036. Epub 2016 Aug 26.
3
The impact of human immunodeficiency virus (HIV) co-infection on the economic burden of cutaneous leishmaniasis (CL) in Brazil and potential value of new CL drug treatments.
Am J Trop Med Hyg. 2014 Sep;91(3):520-527. doi: 10.4269/ajtmh.13-0309. Epub 2014 Jul 7.
4
A passive cold storage device economic model to evaluate selected immunization location scenarios.
Vaccine. 2013 Oct 25;31(45):5232-8. doi: 10.1016/j.vaccine.2013.08.079. Epub 2013 Sep 7.
5
Augmenting transport versus increasing cold storage to improve vaccine supply chains.
PLoS One. 2013 May 22;8(5):e64303. doi: 10.1371/journal.pone.0064303. Print 2013.
6
Removing the regional level from the Niger vaccine supply chain.
Vaccine. 2013 Jun 10;31(26):2828-34. doi: 10.1016/j.vaccine.2013.04.011. Epub 2013 Apr 17.
7
Global economic burden of Chagas disease: a computational simulation model.
Lancet Infect Dis. 2013 Apr;13(4):342-8. doi: 10.1016/S1473-3099(13)70002-1. Epub 2013 Feb 8.
8
Prevention of influenza in healthy children.
Expert Rev Anti Infect Ther. 2012 Oct;10(10):1139-52. doi: 10.1586/eri.12.106.
9
Simulation shows hospitals that cooperate on infection control obtain better results than hospitals acting alone.
Health Aff (Millwood). 2012 Oct;31(10):2295-303. doi: 10.1377/hlthaff.2011.0992.
10
The impact of making vaccines thermostable in Niger's vaccine supply chain.
Vaccine. 2012 Aug 17;30(38):5637-43. doi: 10.1016/j.vaccine.2012.06.087. Epub 2012 Jul 10.
本文引用的文献
1
Cost-effectiveness of alternative blood-screening strategies for West Nile Virus in the United States.
PLoS Med. 2006 Feb;3(2):e21. doi: 10.1371/journal.pmed.0030021. Epub 2006 Jan 24.
2
Meeting transfusion safety expectations.
Ann Intern Med. 2005 Oct 4;143(7):537-8. doi: 10.7326/0003-4819-143-7-200510040-00012.
3
The cost-effectiveness of screening the U.S. blood supply for West Nile virus.
Ann Intern Med. 2005 Oct 4;143(7):486-92. doi: 10.7326/0003-4819-143-7-200510040-00007.
4
Problem solved? West Nile virus and transfusion safety.
N Engl J Med. 2005 Aug 4;353(5):516-7. doi: 10.1056/NEJMe058144.
5
West Nile virus economic impact, Louisiana, 2002.
Emerg Infect Dis. 2004 Oct;10(10):1736-44. doi: 10.3201/eid1010.030925.
6
Pharmaceuticals and worker productivity loss: a critical review of the literature.
J Occup Environ Med. 2003 Jun;45(6):610-21. doi: 10.1097/01.jom.0000069244.06498.01.
7
The economic burden of non-influenza-related viral respiratory tract infection in the United States.
Arch Intern Med. 2003 Feb 24;163(4):487-94. doi: 10.1001/archinte.163.4.487.
8
Investigations of West Nile virus infections in recipients of blood transfusions.
MMWR Morb Mortal Wkly Rep. 2002 Nov 1;51(43):973-4.
Zotero 插件